Opendata, web and dolomites

MINAPATH

MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MINAPATH project word cloud

Explore the words cloud of the MINAPATH project. It provides you a very rough idea of what is the project "MINAPATH" about.

population    healthcare    unknown    impacts    faces    hazard    society    deteriorating    silica    cadmium    critical    financial    workplace    carcinogenic    construction    pulmonary    ageing    underlying    quality    efficiency    diagnose    patient    dusts    billion    sustainability    environment    globally    finalise    efficient    effort    undiagnosed    feasibility    inflammatory    specially    fall    expenditure    asbestos    influencing    slowly    made    accurate    serving    category    diagnostic    minerals    lung    demonstrating    fast    chronic    deposits    prepare    progressing    commercial    mostly    maturity    risk    coming    exclusion    exposome    metals    industrial    market    carry    diseases    today    once    exposure    quantitative    nickel    people    tests    qualitative    categorized    relationship    mineral    goals    idiopathic    cobalt    despite    life    occupational    cancer    stay    unsustainable    prevalence    settings    therapy    sites    diagnosis    minapath    combines    2050   

Project "MINAPATH" data sheet

The following table provides information about the project.

Coordinator
MINAPATH DEVELOPPEMENT 

Organization address
address: 56 BD NIELS BOHR CENTRE D ENTREPRISE ET D INNOVATION 2
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.minapath.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MINAPATH DEVELOPPEMENT FR (VILLEURBANNE) coordinator 50˙000.00

Map

 Project objective

Today healthcare faces critical challenges coming from an ageing population and the rise of chronic diseases. With a population expected to reach 9 billion people by 2050, healthcare expenditure is at risk of becoming unsustainable. Sustainability requires diagnostic methods to become more efficient, fast and accurate, to facilitate the use of adequate therapy. Despite the effort being made, there are still many diseases that get categorized as idiopathic (unknown cause). Specially in the lung, many inflammatory conditions fall under idiopathic category and stay undiagnosed, while slowly progressing, deteriorating the patient’s quality of life. However, many idiopathic conditions do have a common factor: exposure to mineral dusts such as asbestos, silica or metals (nickel, cadmium & cobalt). We are all at risk of exposure to these minerals, from the environment and workplace, being an occupational hazard in industrial settings and construction sites. Importantly, many of these mineral dusts are carcinogenic, contributing to the increasing prevalence of cancer globally. Despite their impact, today there are no dedicated diagnostic tests to assess mineral exposure, and diagnosis is mostly based on exclusion. In response, we at Minapath have developed a unique method that combines qualitative & quantitative analysis to diagnose the patient’s mineral exposome, serving to identify the underlying cause behind many cases of inflammatory & cancer conditions. After demonstrating the diagnostic relationship between mineral deposits and idiopathic pulmonary diseases, our goal with this project is to finalise the development of our technology and reach market maturity. To achieve these goals, in Phase 1 we aim to carry a Feasibility Study that help us prepare for the main technical, commercial and financial aspects influencing the project. Once completed, our technology will bring significant impacts to society and healthcare, contributing to its efficiency and sustainability.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MINAPATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MINAPATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More  

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More